Telangiectasia, Hereditary Hemorrhagic
-
Subject Areas on Research
-
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).
-
A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34.
-
A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2.
-
A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12.
-
Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
-
Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
-
COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II.
-
Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?
-
Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred.
-
Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1.
-
Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report.
-
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.
-
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.
-
Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia.
-
Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.
-
Genetic abnormalities in hereditary hemorrhagic telangiectasia.
-
Genetic heterogeneity in hereditary haemorrhagic telangiectasia.
-
Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype.
-
Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
-
Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment with transcatheter embolization.
-
Hereditary hemorrhagic telangiectasia.
-
Hereditary hemorrhagic telangiectasia.
-
Hereditary hemorrhagic telangiectasia.
-
Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family.
-
Intraoperative choroidal hemorrhage in the Osler-Rendu-Weber syndrome.
-
Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia.
-
Methylene blue in congenital methemoglobinemia: prophylactic or on demand?
-
Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles.
-
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.
-
Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia. Mutations in brief no. 164. Online.
-
Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome.
-
Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations.
-
Predictors of mortality in patients with hereditary hemorrhagic telangiectasia.
-
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.
-
Quantification metrics for telangiectasia using optical coherence tomography.
-
Quantitative DNA pooling to increase the efficiency of linkage analysis in autosomal dominant disease.
-
Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.
-
Report on the workshop on Hereditary Hemorrhagic Telangiectasia, July 10-11, 1997.
-
Role of transforming growth factor beta in human disease.
-
SMAD4 mutations found in unselected HHT patients.
-
Signaling by the transforming growth factor-beta receptors.
-
Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function.
-
Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
-
The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.
-
The molecular genetics of hereditary hemorrhagic telangiectasia.
-
Thoracic endografting in a patient with hereditary hemorrhagic telangiectasia presenting with a descending thoracic aneurysm.
-
Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: evidence for a founder effect.
-
Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia.
-
Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
-
Vascular morphogenesis: tales of two syndromes.
-
Keywords of People